全身炎症反应指数、血小板与淋巴细胞比率与急性缺血性卒中严重程度的相关性研究
Correlation of Systemic Inflammatory Response Index and Platelet-to-Lymphocyte Ratio with Acute Ischemic Stroke Severity
DOI: 10.12677/acm.2025.15102780, PDF,    科研立项经费支持
作者: 苏小航, 王 哲, 李春晓, 赵矍煜, 王三奇, 周芯宇, 李 鑫*:青岛大学附属医院神经内科,山东 青岛;青岛大学青岛医学院,山东 青岛
关键词: 全身炎症反应指数血小板与淋巴细胞比率缺血性卒中卒中严重程度Systemic Inflammatory Response Index Platelet-to-Lymphocyte Ratio Acute Ischemic Stroke Stroke Severity
摘要: 目的:炎症在急性缺血性卒中(AIS)的病理生理学中起着关键作用。本研究旨在探讨全身炎症反应指数(SIRI)、血小板与淋巴细胞比率(PLR)与AIS严重程度之间的关系。并评估炎症标志物对AIS病情严重程度的预测价值。方法:本研究回顾性纳入符合标准的417例AIS患者,入院时采集血细胞计数,并采用美国国立卫生研究院卒中量表(NIHSS)评估卒中严重程度。SIRI定义为中性粒细胞计数 × 单核细胞计数/淋巴细胞计数。PLR定义为血小板计数/淋巴细胞计数。采用多元Logistic回归分析影响缺血性脑卒中严重程度的独立危险因素。并绘制受试者工作特征(ROC)曲线评估SIRI和PLR在脑卒中疾病严重程度中的判别效能。结果:中重度卒中组的SIRI和PLR水平均显著高于轻度卒中组[SIRI: 1.30 (0.81~1.80) vs. 0.88 (0.62~1.26), P < 0.001; PLR: 141.45 (109.30~191.04) vs. 121.23 (92.65~150.68), P < 0.001]。单因素和多因素Logistic回归分析进一步表明,SIRI (OR: 1.877, 95% CI: 1.272~2.772, P = 0.002)和PLR (OR: 1.005, 95% CI: 1.001~1.010, P = 0.022)均与卒中严重程度独立相关。ROC曲线分析显示,SIRI (AUC = 0.679,灵敏度为0.567,特异度为0.728)和PLR (AUC = 0.634,灵敏度为0.653,特异度为0.592)对脑卒中严重程度具有中等偏低的预测能力,其中SIRI的判别效能略优于PLR。结论:SIRI和PLR与入院时的卒中严重程度显著相关,可作为与疾病严重程度相关的辅助炎症生物标志物。然而,其预测能力有限,不能替代标准的临床评估。未来仍需开展大样本、多中心研究进一步验证。
Abstract: Objective: Inflammation plays a critical role in the pathophysiology of acute ischemic stroke (AIS). This study aimed to investigate the relationship between the systemic inflammatory response index (SIRI), platelet-to-lymphocyte ratio (PLR), and AIS severity, as well as to evaluate the predictive value of these inflammatory markers for stroke severity. Methods: This retrospective study enrolled 417 eligible AIS patients. Blood cell counts were collected upon admission, and stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS). SIRI was defined as neutrophil count × monocyte count/lymphocyte count. PLR was defined as platelet count/lymphocyte count. Multivariate Logistic regression analysis was used to identify independent risk factors associated with stroke severity. Receiver operating characteristic (ROC) curves were plotted to assess the discriminatory ability of SIRI and PLR for stroke severity. Results: The moderate-to-severe stroke group exhibited significantly higher SIRI and PLR levels compared to the mild stroke group [SIRI: 1.30 (0.81~1.80) vs. 0.88 (0.62~1.26), P < 0.001; PLR: 141.45 (109.30~191.04) vs. 121.23 (92.65~150.68), P < 0.001]. Univariate and multivariate Logistic regression analyses further demonstrated that SIRI (OR: 1.877, 95% CI: 1.272~2.772, P = 0.002) and PLR (OR: 1.005, 95% CI: 1.001~1.010, P = 0.022) were independently associated with stroke severity. ROC curve analysis showed that SIRI (AUC = 0.679, sensitivity = 0.567, specificity = 0.728) and PLR (AUC = 0.634, sensitivity = 0.653, specificity = 0.592) had relatively low-to-moderate predictive ability for stroke severity, with SIRI showing slightly better discriminatory performance than PLR. Conclusion: Both SIRI and PLR were significantly associated with stroke severity at admission and may serve as auxiliary inflammatory biomarkers related to disease severity. However, their predictive value is limited and cannot replace standard clinical assessments. Large-scale, multicenter studies are needed for further validation.
文章引用:苏小航, 王哲, 李春晓, 赵矍煜, 王三奇, 周芯宇, 李鑫. 全身炎症反应指数、血小板与淋巴细胞比率与急性缺血性卒中严重程度的相关性研究[J]. 临床医学进展, 2025, 15(10): 475-484. https://doi.org/10.12677/acm.2025.15102780

参考文献

[1] Global Burden of Disease Study 2021 Collaborators (2024) Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021. Lancet, 403, 2100-2132. [Google Scholar] [CrossRef
[2] Anrather, J. and Iadecola, C. (2016) Inflammation and Stroke: An Overview. Neurotherapeutics, 13, 661-670. [Google Scholar] [CrossRef] [PubMed]
[3] Zhang, W., Song, J., Li, W., Kong, D., Liang, Y., Zhao, X., et al. (2020) Salvianolic Acid D Alleviates Cerebral Ischemia-Reperfusion Injury by Suppressing the Cytoplasmic Translocation and Release of Hmgb1-Triggered NF-κB Activation to Inhibit Inflammatory Response. Mediators of Inflammation, 2020, Article ID: 9049614. [Google Scholar] [CrossRef] [PubMed]
[4] Dang, H., Mao, W., Wang, S., Sha, J., Lu, M., Cong, L., et al. (2023) Systemic Inflammation Response Index as a Prognostic Predictor in Patients with Acute Ischemic Stroke: A Propensity Score Matching Analysis. Frontiers in Neurology, 13, Article 1049241. [Google Scholar] [CrossRef] [PubMed]
[5] Chen, C., Gu, L., Chen, L., Hu, W., Feng, X., Qiu, F., et al. (2021) Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Potential Predictors of Prognosis in Acute Ischemic Stroke. Frontiers in Neurology, 11, Article 525621. [Google Scholar] [CrossRef] [PubMed]
[6] Lee, S., Song, D., Ryu, H., Kim, Y., Kim, T. and Joo, S. (2021) Systemic Macrophage Depletion Attenuates Infarct Size in an Experimental Mouse Model of Stroke. Journal of Cerebrovascular and Endovascular Neurosurgery, 23, 304-313. [Google Scholar] [CrossRef] [PubMed]
[7] Luo, J., Cai, Y., Xiao, P., Cao, C., Huang, M., Zhang, X., et al. (2024) Inflammation‐Derived and Clinical Indicator‐based Predictive Model for Ischemic Stroke Recovery. Journal of the American Heart Association, 13, e035609. [Google Scholar] [CrossRef] [PubMed]
[8] Boltze, J. and Perez-Pinzon, M.A. (2022) Focused Update on Stroke Neuroimmunology: Current Progress in Preclinical and Clinical Research and Recent Mechanistic Insight. Stroke, 53, 1432-1437. [Google Scholar] [CrossRef] [PubMed]
[9] Ma, F., Li, L., Xu, L., Wu, J., Zhang, A., Liao, J., et al. (2023) The Relationship between Systemic Inflammation Index, Systemic Immune-Inflammatory Index, and Inflammatory Prognostic Index and 90-Day Outcomes in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis. Journal of Neuroinflammation, 20, Article No. 220. [Google Scholar] [CrossRef] [PubMed]
[10] Zhou, Y., Zhang, Y., Cui, M., Zhang, Y. and Shang, X. (2022) Prognostic Value of the Systemic Inflammation Response Index in Patients with Acute Ischemic Stroke. Brain and Behavior, 12, e2619. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, Y., Qi, S., Yu, Z., Li, J., Qian, T., Zeng, Y., et al. (2023) Systemic Inflammation Response Index Predicts Clinical Outcomes in Patients with Acute Ischemic Stroke (AIS) after the Treatment of Intravenous Thrombolysis. The Neurologist, 28, 355-361. [Google Scholar] [CrossRef] [PubMed]
[12] Han, J., Yang, L., Lou, Z. and Zhu, Y. (2023) Association between Systemic Immune-Inflammation Index and Systemic Inflammation Response Index and Outcomes of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Annals of Indian Academy of Neurology, 26, 655-662. [Google Scholar] [CrossRef] [PubMed]
[13] Zhang, Y., Xing, Z., Zhou, K. and Jiang, S. (2021) The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients. Clinical Interventions in Aging, 16, 1997-2007. [Google Scholar] [CrossRef] [PubMed]
[14] Xu, J., He, X., Li, Q., Liu, J., Zhuang, M., Huang, F., et al. (2019) Higher Platelet-to-Lymphocyte Ratio Is Associated with Worse Outcomes after Intravenous Thrombolysis in Acute Ischaemic Stroke. Frontiers in Neurology, 10, Article 1192. [Google Scholar] [CrossRef] [PubMed]
[15] Gary, T., Pichler, M., Belaj, K., Hafner, F., Gerger, A., Froehlich, H., et al. (2013) Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients. PLOS ONE, 8, e67688. [Google Scholar] [CrossRef] [PubMed]
[16] Altintas, O., Tasal, A., Niftaliyev, E., Kucukdagli, O.T. and Asil, T. (2016) Association of Platelet-to-Lymphocyte Ratio with Silent Brain Infarcts in Patients with Paroxysmal Atrial Fibrillation. Neurological Research, 38, 753-758. [Google Scholar] [CrossRef] [PubMed]
[17] Akopov, S.E., Simonian, N.A. and Grigorian, G.S. (1996) Dynamics of Polymorphonuclear Leukocyte Accumulation in Acute Cerebral Infarction and Their Correlation with Brain Tissue Damage. Stroke, 27, 1739-1743. [Google Scholar] [CrossRef] [PubMed]
[18] Buck, B.H., Liebeskind, D.S., Saver, J.L., Bang, O.Y., Yun, S.W., Starkman, S., et al. (2008) Early Neutrophilia Is Associated with Volume of Ischemic Tissue in Acute Stroke. Stroke, 39, 355-360. [Google Scholar] [CrossRef] [PubMed]
[19] Jin, W., Gonzales, R., Feng, Y., Wood, K., Chai, Z., Dong, J., et al. (2018) Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury. Stroke, 49, 1471-1478. [Google Scholar] [CrossRef] [PubMed]
[20] Yamamoto, Y., Osanai, T., Nishizaki, F., Sukekawa, T., Izumiyama, K., Sagara, S., et al. (2012) Matrix Metalloprotein-9 Activation under Cell-to-Cell Interaction between Endothelial Cells and Monocytes: Possible Role of Hypoxia and Tumor Necrosis Factor-α. Heart and Vessels, 27, 624-633. [Google Scholar] [CrossRef] [PubMed]
[21] Dong, X., Nao, J. and Gao, Y. (2019) Peripheral Monocyte Count Predicts Outcomes in Patients with Acute Ischemic Stroke Treated with rtPA Thrombolysis. Neurotoxicity Research, 37, 469-477. [Google Scholar] [CrossRef] [PubMed]
[22] Liberale, L., Montecucco, F., Bonaventura, A., Casetta, I., Seraceni, S., Trentini, A., et al. (2017) Monocyte Count at Onset Predicts Poststroke Outcomes during a 90-Day Follow-Up. European Journal of Clinical Investigation, 47, 702-710. [Google Scholar] [CrossRef] [PubMed]
[23] Liesz, A., Zhou, W., Na, S., Hämmerling, G.J., Garbi, N., Karcher, S., et al. (2013) Boosting Regulatory T Cells Limits Neuroinflammation in Permanent Cortical Stroke. The Journal of Neuroscience, 33, 17350-17362. [Google Scholar] [CrossRef] [PubMed]
[24] Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., et al. (2009) Regulatory T Cells Are Key Cerebroprotective Immunomodulators in Acute Experimental Stroke. Nature Medicine, 15, 192-199. [Google Scholar] [CrossRef] [PubMed]
[25] Huang, Y., Yin, X. and Li, Z. (2022) Association of the Systemic Immune-Inflammation Index (SII) and Clinical Outcomes in Patients with Stroke: A Systematic Review and Meta-analysis. Frontiers in Immunology, 13, Article 1090305. [Google Scholar] [CrossRef] [PubMed]
[26] Denorme, F., Rustad, J.L. and Campbell, R.A. (2021) Brothers in Arms: Platelets and Neutrophils in Ischemic Stroke. Current Opinion in Hematology, 28, 301-307. [Google Scholar] [CrossRef] [PubMed]
[27] Wang, J., Zhang, X., Tian, J., Li, H., Tang, H. and Yang, C. (2022) Predictive Values of Systemic Inflammatory Responses Index in Early Neurological Deterioration in Patients with Acute Ischemic Stroke. Journal of Integrative Neuroscience, 21, 94. [Google Scholar] [CrossRef] [PubMed]
[28] Gong, P., Liu, Y., Gong, Y., Chen, G., Zhang, X., Wang, S., et al. (2021) The Association of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Lymphocyte to Monocyte Ratio with Post-Thrombolysis Early Neurological Outcomes in Patients with Acute Ischemic Stroke. Journal of Neuroinflammation, 18, 51. [Google Scholar] [CrossRef] [PubMed]
[29] Kolosowska, N., Keuters, M.H., Wojciechowski, S., Keksa-Goldsteine, V., Laine, M., Malm, T., et al. (2019) Peripheral Administration of IL-13 Induces Anti-Inflammatory Microglial/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke. Neurotherapeutics, 16, 1304-1319. [Google Scholar] [CrossRef] [PubMed]
[30] Feng, L., Dou, C., Xia, Y., Li, B., Zhao, M., Yu, P., et al. (2021) Neutrophil-Like Cell-Membrane-Coated Nanozyme Therapy for Ischemic Brain Damage and Long-Term Neurological Functional Recovery. ACS Nano, 15, 2263-2280. [Google Scholar] [CrossRef] [PubMed]
[31] Zheng, Y., He, R., Wang, P., Shi, Y., Zhao, L. and Liang, J. (2019) Exosomes from LPS-Stimulated Macrophages Induce Neuroprotection and Functional Improvement after Ischemic Stroke by Modulating Microglial Polarization. Biomaterials Science, 7, 2037-2049. [Google Scholar] [CrossRef] [PubMed]
[32] Brait, V.H., Tarrasón, G., Gavaldà, A., Godessart, N. and Planas, A.M. (2016) Selective Sphingosine 1-Phosphate Receptor 1 Agonist Is Protective against Ischemia/Reperfusion in Mice. Stroke, 47, 3053-3056. [Google Scholar] [CrossRef] [PubMed]